drugset / Trial / NCT02040376

Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma

NCT02040376 ↗

Phase 3 Completed 24 enrolled The Hospital for Sick Children
RandomizedCrossoverQuadruple-blindTreatment

Summary

A placebo controlled double blind crossover trial of metformin in 30 children treated with radiation for medulloblastoma - the most common malignant brain tumour. The investigators used tests of thinking and learning and brain imaging techniques to examine whether metformin can enhance cognition or promote brain repair following radiation-induced brain injury.

Timeline

Start
2014-06-13
Primary completion
2017-12-15
Completion
2017-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg/m2 Oral

Indications